A Phase 1 Study of PM54 in Advanced Solid Tumors
Recruiting Phase 1 NCT05841563
Study Description
A Clinical Trial Evaluating a New Drug Called PM54 for the Treatment of Advanced Solid Tumors
Study Details
- Registry ID:
- NCT05841563
- Conditions:
- Advanced Solid Tumor
- Phase:
- Phase 1
- Target Enrollment:
- 125 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (3 sites)
-
HM Universitario Sanchinarro
Madrid, M, Spain -
Institut Jules Bordet
Anderlecht, Belgium -
South Texas Accelerated Research Therapeutics
San Antonio, Texas, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.